Literature DB >> 23729441

Phosphatidylinositol 3-kinase-independent signaling pathways contribute to ICOS-mediated T cell costimulation in acute graft-versus-host disease in mice.

Jun Li1, Jessica Heinrichs, Julien Leconte, Kelley Haarberg, Kenrick Semple, Chen Liu, Mathieu Gigoux, Mara Kornete, Ciriaco A Piccirillo, Woong-Kyung Suh, Xue-Zhong Yu.   

Abstract

We and others have previously shown that ICOS plays an important role in inducing acute graft-versus-host disease (GVHD) in murine models of allogeneic bone marrow transplantation. ICOS potentiates TCR-mediated PI3K activation and intracellular calcium mobilization. However, ICOS signal transduction pathways involved in GVHD remain unknown. In this study, we examined the contribution of ICOS-PI3K signaling in the pathogenic potential of T cells using a knock-in mouse strain, ICOS-YF, which selectively lost the ability to activate PI3K. We found that when total T cells were used as alloreactive T cells, ICOS-YF T cells caused less severe GVHD compared with ICOS wild-type T cells, but they induced much more aggressive disease than ICOS knockout T cells. This intermediate level of pathogenic capacity of ICOS-YF T cells was correlated with similar levels of IFN-γ-producing CD8 T cells that developed in the recipients of ICOS-WT or ICOS-YF T cells. We further evaluated the role of ICOS-PI3K signaling in CD4 versus CD8 T cell compartment using GVHD models that are exclusively driven by CD4 or CD8 T cells. Remarkably, ICOS-YF CD8 T cells caused disease similar to ICOS wild-type CD8 T cells, whereas ICOS-YF CD4 T cells behaved very similarly to their ICOS knockout counterparts. Consistent with their in vivo pathogenic potential, CD8 T cells responded to ICOS ligation in vitro by PI3K-independent calcium flux, T cell activation, and proliferation. Thus, in acute GVHD in mice, CD4 T cells heavily rely on ICOS-PI3K signaling pathways; in contrast, CD8 T cells can use PI3K-independent ICOS signaling pathways, possibly through calcium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23729441      PMCID: PMC4318500          DOI: 10.4049/jimmunol.1203485

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.

Authors:  J L Riley; P J Blair; J T Musser; R Abe; K Tezuka; T Tsuji; C H June
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

2.  The CD28-related molecule ICOS is required for effective T cell-dependent immune responses.

Authors:  A J Coyle; S Lehar; C Lloyd; J Tian; T Delaney; S Manning; T Nguyen; T Burwell; H Schneider; J A Gonzalo; M Gosselin; L R Owen; C E Rudd; J C Gutierrez-Ramos
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

3.  ICOS is essential for effective T-helper-cell responses.

Authors:  A Tafuri; A Shahinian; F Bladt; S K Yoshinaga; M Jordana; A Wakeham; L M Boucher; D Bouchard; V S Chan; G Duncan; B Odermatt; A Ho; A Itie; T Horan; J S Whoriskey; T Pawson; J M Penninger; P S Ohashi; T W Mak
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

4.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.

Authors:  M M Swallow; J J Wallin; W C Sha
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

5.  A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T(h) cells and regulates their responses.

Authors:  Yutaka Arimura; Hidehito Kato; Umberto Dianzani; Toshihiro Okamoto; Soichiro Kamekura; Donatella Buonfiglio; Tohru Miyoshi-Akiyama; Takehiko Uchiyama; Junji Yagi
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

6.  ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.

Authors:  Saman Khayyamian; Andreas Hutloff; Kerstin Büchner; Michael Gräfe; Volker Henn; Richard A Kroczek; Hans W Mages
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

7.  Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease.

Authors:  S Ogawa; G Nagamatsu; M Watanabe; S Watanabe; T Hayashi; S Horita; K Nitta; H Nihei; K Tezuka; R Abe
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

8.  CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.

Authors:  Richard V Parry; Catherine A Rumbley; Luk H Vandenberghe; Carl H June; James L Riley
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

9.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

10.  Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling.

Authors:  Linda Liang; Evelyn M Porter; William C Sha
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Cytokines and costimulation in acute graft-versus-host disease.

Authors:  Geoffrey R Hill; Motoko Koyama
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  Phosphoinositide 3-kinase δ is a regulatory T-cell target in cancer immunotherapy.

Authors:  Ee Lyn Lim; Klaus Okkenhaug
Journal:  Immunology       Date:  2019-07       Impact factor: 7.397

3.  Chitinase 3-Like-1-Deficient Splenocytes Deteriorated the Pathogenesis of Acute Graft-Versus-Host Disease via Regulating Differentiation of Tfh Cells.

Authors:  Zengyao Li; Hao Lu; Jian Gu; Jing Liu; Qin Zhu; Yunjie Lu; Xuehao Wang
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

Review 4.  A three-signal model of T-cell lymphoma pathogenesis.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-17       Impact factor: 10.047

5.  Immunomodulation of Selective Naive T Cell Functions by p110δ Inactivation Improves the Outcome of Mismatched Cell Transplantation.

Authors:  Jean-Marc Doisne; Christian M Hüber; Klaus Okkenhaug; Francesco Colucci
Journal:  Cell Rep       Date:  2015-02-05       Impact factor: 9.423

6.  Development of interleukin-17-producing Vγ2+ γδ T cells is reduced by ICOS signaling in the thymus.

Authors:  Terkild Brink Buus; Jonas Damgård Schmidt; Charlotte Menné Bonefeld; Carsten Geisler; Jens Peter Holst Lauritsen
Journal:  Oncotarget       Date:  2016-04-12

Review 7.  ICOS Co-Stimulation: Friend or Foe?

Authors:  Daniel J Wikenheiser; Jason S Stumhofer
Journal:  Front Immunol       Date:  2016-08-10       Impact factor: 7.561

Review 8.  Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses.

Authors:  Christophe Pedros; Amnon Altman; Kok-Fai Kong
Journal:  Front Immunol       Date:  2018-10-22       Impact factor: 7.561

9.  A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1.

Authors:  Christophe Pedros; Yaoyang Zhang; Joyce K Hu; Youn Soo Choi; Ann J Canonigo-Balancio; John R Yates; Amnon Altman; Shane Crotty; Kok-Fai Kong
Journal:  Nat Immunol       Date:  2016-05-02       Impact factor: 25.606

10.  Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation.

Authors:  Anne-Katrien Stark; Elizabeth C M Davenport; Daniel T Patton; Cheryl L Scudamore; Bart Vanhaesebroeck; Marc Veldhoen; Oliver A Garden; Klaus Okkenhaug
Journal:  J Immunol       Date:  2020-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.